| scholarly article | Q13442814 |
| P50 | author | Rino Rappuoli | Q2154243 |
| Dominique A Caugant | Q57906958 | ||
| Mariagrazia Pizza | Q100420770 | ||
| Maurizio Comanducci | Q114738848 | ||
| Stefania Bambini | Q114738849 | ||
| Brunella Brunelli | Q114738850 | ||
| Barbara Capecchi | Q114738853 | ||
| Marirosa Mora | Q114738855 | ||
| Laura Ciucchi | Q114738870 | ||
| P2860 | cites work | Topology of outer membrane porins in pathogenic Neisseria spp | Q24643005 |
| NadA, a novel vaccine candidate of Neisseria meningitidis | Q24675323 | ||
| Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms | Q24685491 | ||
| Update on meningococcal disease with emphasis on pathogenesis and clinical management | Q33812435 | ||
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. | Q33892877 | ||
| Carried meningococci in the Czech Republic: a diverse recombining population | Q33970597 | ||
| Development of vaccines against meningococcal disease | Q34623334 | ||
| Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains | Q35606338 | ||
| Capsule switching of Neisseria meningitidis | Q35910306 | ||
| Human immunity to the meningococcus. II. Development of natural immunity | Q36269758 | ||
| Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis | Q36505316 | ||
| Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. | Q37071251 | ||
| Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination | Q39458286 | ||
| Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins | Q40388219 | ||
| Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children | Q41367652 | ||
| Many carried meningococci lack the genes required for capsule synthesis and transport | Q43450474 | ||
| Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis | Q47854732 | ||
| Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers | Q70144516 | ||
| Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species | Q73367899 | ||
| Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand | Q73998641 | ||
| Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica | Q77788288 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biodiversity | Q47041 |
| Neisseria meningitidis | Q154625 | ||
| P304 | page(s) | 4217-4223 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | NadA diversity and carriage in Neisseria meningitidis | |
| P478 | volume | 72 |
| Q37878478 | A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. |
| Q38200261 | A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty |
| Q38040527 | Advances with vaccination against Neisseria meningitidis |
| Q34746633 | An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands |
| Q90366018 | An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis |
| Q46265378 | An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt |
| Q26783530 | Anti-infective vaccination in the 21st century-new horizons for personal and public health |
| Q34584506 | Attachment and invasion of Neisseria meningitidis to host cells is related to surface hydrophobicity, bacterial cell size and capsule |
| Q92156626 | Atypical, Yet Not Infrequent, Infections with Neisseria Species |
| Q37994540 | Bexsero: a multicomponent vaccine for prevention of meningococcal disease. |
| Q48138824 | Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection |
| Q52352963 | Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design. |
| Q39410503 | Biological Functions of the Secretome of Neisseria meningitidis |
| Q59244167 | Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine |
| Q33696949 | Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease |
| Q30248749 | Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). |
| Q50857953 | Characterization of ST-4821 complex, a unique Neisseria meningitidis clone. |
| Q41012990 | Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine |
| Q41845489 | Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q36936278 | Conservation of meningococcal antigens in the genus Neisseria |
| Q38011317 | Considerations for controlling invasive meningococcal disease in high income countries |
| Q40268050 | Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model |
| Q39981028 | Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus |
| Q33600936 | Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine |
| Q30234958 | Emerging experience with meningococcal serogroup B protein vaccines |
| Q35806559 | FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression |
| Q37694838 | Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy |
| Q37469617 | Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica |
| Q37798011 | Genetic shifts ofNeisseria meningitidisserogroup B antigens and the quest for a broadly cross-protective vaccine |
| Q42957071 | Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells |
| Q44358302 | Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion |
| Q54426056 | Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA). |
| Q52682421 | Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes. |
| Q35690291 | IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone |
| Q54458667 | Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes. |
| Q64951753 | In silico Homology Modeling and Epitope Prediction of NadA as a Potential Vaccine Candidate in Neisseria meningitidis. |
| Q61293682 | Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection |
| Q43519880 | Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. |
| Q35845900 | Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. |
| Q36711465 | Lessons from meningococcal carriage studies |
| Q24600500 | Mapping of theNeisseria meningitidisNadA Cell-Binding Site: Relevance of Predicted α-Helices in the NH2-Terminal and Dimeric Coiled-Coil Regions |
| Q54329423 | Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus. |
| Q89959890 | Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil |
| Q37501041 | Meningococcal interactions with the host |
| Q37501047 | Meningococcal protein antigens and vaccines |
| Q35871107 | Meningococcal vaccine antigen diversity in global databases |
| Q33928490 | Microsatellite instability regulates transcription factor binding and gene expression |
| Q33372688 | Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells |
| Q33703560 | Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. |
| Q42088370 | Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil. |
| Q28731309 | Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil |
| Q57459048 | NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies |
| Q52628111 | Neisseria Meningitidis Serogroup B Carriage By Adolescents And Young Adults Living In Milan, Italy: Prevalence Of Strains Potentially Covered By Thepresently Available Meningococcal B Vaccines. |
| Q42735385 | Neisseria adhesin A variation and revised nomenclature scheme |
| Q39563173 | Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasin |
| Q37878480 | New frontiers in meningococcal vaccines |
| Q35887397 | Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant |
| Q38325374 | Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives |
| Q37415301 | Pathogenic neisseriae: surface modulation, pathogenesis and infection control |
| Q58701015 | Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine |
| Q39466320 | Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment |
| Q52361221 | Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China. |
| Q64128195 | Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States |
| Q42280033 | Prevalence and genetic diversity of two adhesion-related genes, pilE and nadA, in Neisseria meningitidis in China |
| Q83222896 | Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease |
| Q34776964 | Progressive decrease in the potential usefulness of meningococcal serogroup B vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain |
| Q24537338 | Prospects for vaccine prevention of meningococcal infection |
| Q30230636 | Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens. |
| Q42232579 | Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. |
| Q64073032 | Protocol for a controlled human infection with genetically modified expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine |
| Q37880078 | Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles |
| Q33646965 | Review of meningococcal group B vaccines |
| Q27335545 | Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cells |
| Q84346977 | Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis |
| Q44033142 | Serum cross-reaction among virulence-associated trimeric autotransporters (VtaA) of Haemophilus parasuis. |
| Q38606992 | Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci |
| Q43455107 | Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level |
| Q34661129 | Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody |
| Q37651436 | The biology of Neisseria adhesins. |
| Q35989852 | The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens |
| Q38677309 | The next chapter for group B meningococcal vaccines |
| Q28740303 | The soluble recombinant Neisseria meningitidis adhesin NadA(Δ351-405) stimulates human monocytes by binding to extracellular Hsp90 |
| Q36689026 | Towards a universal group B Streptococcus vaccine using multistrain genome analysis |
| Q36340099 | Transcriptomic buffering of cryptic genetic variation contributes to meningococcal virulence |
| Q37274707 | Vaccine development against Neisseria meningitidis |
| Q33348906 | Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae |
Search more.